Park Medi World IPO Day 2 shows GMP at ₹14 (9% premium), down from 13%, signaling modest listing pop around ₹176-183. Subscription reaches 0.56x overall (retail 0.67x), with QIBs at 0.28x. Healthcare chain's ₹920 Cr issue attracts cautious bids amid strong fundamentals.
North India's multi-super specialty hospital chain Park Medi World sees tempered Day 2 momentum in its ₹920 Cr IPO (Dec 10-12, ₹154-162 band). Grey market premium slipped to ₹14 (9%), implying listing near ₹176 vs Day 1's higher 13% buzz, per ET reports.
Subscription hit 0.56x (2.24 Cr shares bid vs 3.98 Cr offered), led by retail (0.67x) and NII (0.70x), while QIBs lag at 0.28x. Anand Rathi rates "Subscribe-Long Term" for expansion in tier-2/3 markets, PMJAY tailwinds (CAGR 10-12%).
Key Highlights:
GMP Today: ₹14 (9%); expected listing ₹176-183.
Subscription: Overall 0.56x; Retail 0.67x, NII 0.70x, QIB 0.28x.
Issue Details: ₹920 Cr (fresh ₹770 Cr + OFS ₹150 Cr); lot 92 shares (₹14,904).
Valuation: P/E 32.8x FY25; mcap ₹5,356 Cr post-issue.
Recommendation: Long-term buy for healthcare growth; monitor QIB pickup.
Sources: Economic Times, Chittorgarh, Goodreturns.